Functional modulation of liver mitochondria in lipopolysaccharide/drug co-treated rat liver injury model
Open Access
- 1 January 2019
- journal article
- research article
- Published by Japanese Society of Toxicology in The Journal of Toxicological Sciences
- Vol. 44 (12) , 833-843
Abstract
Drug-induced liver injury is not readily detectable using conventional animal studies during pre-clinical drug development. To address this problem, other researchers have proposed the use of co-administration of lipopolysaccharide (LPS), an endotoxin produced by gram-negative bacteria, and a drug. Using this approach, liver injury that is otherwise not detected following drug administration alone can be successfully identified. Previous studies have demonstrated that such injury is suppressed by heparin; therefore, the mechanism may involve coagulation-dependent ischemia. However, it has not been established how LPS-induced ischemia might sensitize hepatocytes to a potentially hepatotoxic drug. In the present study, we aimed to determine the effect of LPS-induced ischemia on liver mitochondrial function and downstream toxicologic responses. Consistent with previous findings, plasma alanine transaminase (ALT) activity was higher in rats co-administered with LPS (1 mg/kg) and diclofenac (100 mg/kg), but reduced by heparin. Liver mRNA expression of Hmox1, encoding heme oxygenase-1, an oxidative stress indicator, was three times higher at 2 hr after LPS administration. Furthermore, respiratory activity via mitochondrial complex II, lipid peroxidation in mitochondria, and the susceptibility to mitochondrial permeability transition pore opening in response to diclofenac administration were significantly increased by LPS administration. The increase in plasma ALT activity and the sensitization to mitochondrial permeability transition pore opening were reduced by the co-administration of heparin. In conclusion, LPS-induced transient ischemia disrupts respiratory chain complex activities, enhances reactive oxygen species production, especially in mitochondria, and sensitizes mitochondria to permeability transition pore opening when testing a potentially hepatotoxic drug in vivo.Keywords
This publication has 49 references indexed in Scilit:
- Integrative Toxicoproteomics Implicates Impaired Mitochondrial Glutathione Import as an Off-Target Effect of TroglitazoneJournal of Proteome Research, 2013
- Prediction of Liver Injury Induced by Chemicals in Human With a Multiparametric Assay on Isolated Mouse Liver MitochondriaToxicological Sciences, 2012
- Mitochondrial permeability transition pore in Alzheimer's disease: Cyclophilin D and amyloid betaBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2010
- Inflammatory Stress and Idiosyncratic Hepatotoxicity: Hints from Animal ModelsPharmacological Reviews, 2009
- Hepatotoxic Interaction of Sulindac with Lipopolysaccharide: Role of the Hemostatic SystemToxicological Sciences, 2008
- Regulation of rat heme oxygenase-1 expression by interleukin-6 via the Jak/STAT pathway in hepatocytesJournal of Hepatology, 2006
- Proteome analysis of rat liver mitochondria reveals a possible compensatory response to endotoxic shockFEBS Letters, 2006
- Cyclophilin D is a component of mitochondrial permeability transition and mediates neuronal cell death after focal cerebral ischemiaProceedings of the National Academy of Sciences, 2005
- Ranitidine Treatment during a Modest Inflammatory Response Precipitates Idiosyncrasy-Like Liver Injury in RatsThe Journal of Pharmacology and Experimental Therapeutics, 2003
- Kupffer cell activation by lipopolysaccharide in rats: Role for lipopolysaccharide binding protein and toll-like receptor 4Hepatology, 2000